
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11486167
[patent_doc_number] => 09592229
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-14
[patent_title] => 'Potent anticancer activity via dual compound activation'
[patent_app_type] => utility
[patent_app_number] => 14/382546
[patent_app_country] => US
[patent_app_date] => 2013-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 9989
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382546
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382546 | Potent anticancer activity via dual compound activation | Mar 3, 2013 | Issued |
Array
(
[id] => 11635053
[patent_doc_number] => 09657013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of use'
[patent_app_type] => utility
[patent_app_number] => 14/382074
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23977
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382074
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382074 | Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of use | Feb 27, 2013 | Issued |
Array
(
[id] => 9086579
[patent_doc_number] => 08558008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Crystalline glycopyrrolate tosylate'
[patent_app_type] => utility
[patent_app_number] => 13/781390
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 10536
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13781390
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/781390 | Crystalline glycopyrrolate tosylate | Feb 27, 2013 | Issued |
Array
(
[id] => 9937497
[patent_doc_number] => 08987305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => '2,4,5-trisubstituted imidazoles and their use as anti-microbial agents'
[patent_app_type] => utility
[patent_app_number] => 13/778458
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16445
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13778458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/778458 | 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents | Feb 26, 2013 | Issued |
Array
(
[id] => 10554740
[patent_doc_number] => 09278936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-08
[patent_title] => 'Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 14/382178
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 39022
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382178
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382178 | Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea hydrochloride | Feb 26, 2013 | Issued |
Array
(
[id] => 10007767
[patent_doc_number] => 09051272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-09
[patent_title] => 'Process for the preparation of phenyl substituted 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid N-methoxy-[1-methyl-2 phenylethyl] amides'
[patent_app_type] => utility
[patent_app_number] => 14/374547
[patent_app_country] => US
[patent_app_date] => 2013-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4181
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374547
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/374547 | Process for the preparation of phenyl substituted 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid N-methoxy-[1-methyl-2 phenylethyl] amides | Feb 25, 2013 | Issued |
Array
(
[id] => 9491677
[patent_doc_number] => 20140142084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/979327
[patent_app_country] => US
[patent_app_date] => 2013-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43285
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979327
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979327 | Nitrogen-containing aromatic heterocyclic compound | Feb 25, 2013 | Issued |
Array
(
[id] => 9910279
[patent_doc_number] => 20150065481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'MICROBIOCIDAL PYRAZOLE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/381028
[patent_app_country] => US
[patent_app_date] => 2013-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13928
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381028
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381028 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | Feb 25, 2013 | Abandoned |
Array
(
[id] => 10148905
[patent_doc_number] => 09181178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Method for producing acrylonitrile'
[patent_app_type] => utility
[patent_app_number] => 14/381047
[patent_app_country] => US
[patent_app_date] => 2013-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10486
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381047
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381047 | Method for producing acrylonitrile | Feb 25, 2013 | Issued |
Array
(
[id] => 8892306
[patent_doc_number] => 20130165490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'INSECTICIDAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/772961
[patent_app_country] => US
[patent_app_date] => 2013-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20874
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13772961
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/772961 | INSECTICIDAL COMPOUNDS | Feb 20, 2013 | Abandoned |
Array
(
[id] => 10187562
[patent_doc_number] => 09216973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-22
[patent_title] => 'Insecticidal compounds'
[patent_app_type] => utility
[patent_app_number] => 13/771829
[patent_app_country] => US
[patent_app_date] => 2013-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23633
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13771829
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/771829 | Insecticidal compounds | Feb 19, 2013 | Issued |
Array
(
[id] => 12954430
[patent_doc_number] => 09837625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => Organic electroluminescent element
[patent_app_type] => utility
[patent_app_number] => 14/381758
[patent_app_country] => US
[patent_app_date] => 2013-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 18029
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381758
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381758 | Organic electroluminescent element | Feb 18, 2013 | Issued |
Array
(
[id] => 9937454
[patent_doc_number] => 08987261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Substituted dihydropyrazolones for treating cardiovascular and hematological diseases'
[patent_app_type] => utility
[patent_app_number] => 13/769513
[patent_app_country] => US
[patent_app_date] => 2013-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41691
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13769513
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/769513 | Substituted dihydropyrazolones for treating cardiovascular and hematological diseases | Feb 17, 2013 | Issued |
Array
(
[id] => 9608488
[patent_doc_number] => 08785656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1H-pyrazole salt'
[patent_app_type] => utility
[patent_app_number] => 13/768519
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4328
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13768519
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/768519 | Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1H-pyrazole salt | Feb 14, 2013 | Issued |
Array
(
[id] => 10961592
[patent_doc_number] => 20140364622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'PROCESS FOR THE STEREOSELECTIVE PREPARATION OF A PYRAZOLE CARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 14/373439
[patent_app_country] => US
[patent_app_date] => 2013-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9050
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373439
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/373439 | Process for the stereoselective preparation of a pyrazole carboxamide | Feb 12, 2013 | Issued |
Array
(
[id] => 9483145
[patent_doc_number] => 08729096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators'
[patent_app_type] => utility
[patent_app_number] => 13/765527
[patent_app_country] => US
[patent_app_date] => 2013-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7488
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13765527
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/765527 | Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators | Feb 11, 2013 | Issued |
Array
(
[id] => 10129188
[patent_doc_number] => 09163013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-20
[patent_title] => 'Use of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/373393
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16480
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373393
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/373393 | Use of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors | Feb 7, 2013 | Issued |
Array
(
[id] => 10975445
[patent_doc_number] => 20140378480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'ANTIVIRAL COMPOUND AND COX-2 INHIBITOR COMBINATION THERAPY FOR FUNCTIONAL SOMATIC SYNDROMES, INCLUDING COMBINATION OF FAMCICLOVIR AND CELECOXIB'
[patent_app_type] => utility
[patent_app_number] => 14/376824
[patent_app_country] => US
[patent_app_date] => 2013-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14422
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376824
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376824 | Antiviral compound and COX-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib | Feb 5, 2013 | Issued |
Array
(
[id] => 8854389
[patent_doc_number] => 20130144064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'MICROBIOCIDAL HETEROCYCLES'
[patent_app_type] => utility
[patent_app_number] => 13/759761
[patent_app_country] => US
[patent_app_date] => 2013-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17438
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13759761
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/759761 | MICROBIOCIDAL HETEROCYCLES | Feb 4, 2013 | Abandoned |
Array
(
[id] => 10226939
[patent_doc_number] => 20150111932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DEGENERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/399528
[patent_app_country] => US
[patent_app_date] => 2013-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9455
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399528
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399528 | Compositions and methods for the treatment of neurological degenerative disorders | Feb 1, 2013 | Issued |